USD 15.5 billion
RNA Analysis Market Size, Share, Growth Analysis, By Technology(Real Time-PCR (qPCR) Technology, Microarray Technology, Sequencing Technology, Others), By Product(Instruments, Kits & Reagents, CHO Media miRNA & siRNA, Reverse Transcriptases & RT-PCR), By Application(Construction of RNA Expression Atlas, Epigenetics, Infectious Diseases & Pathogenesis, Alternative RNA Splicing), By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35H2192 |
Region:
Global |
Published Date: March, 2024
Pages:
219
|Tables:
100
|Figures:
76
RNA Analysis Market Insights
RNA Analysis Market size was valued at USD 16.12 Billion in 2023 and is poised to grow from USD 16.76 Billion in 2024 to USD 22.94 Billion by 2032, growing at a CAGR of 4.00% during the forecast period (2025-2032).
The market is being driven by the increasing adoption of mineral supplements for managing chronic conditions due to a significant portion of the population grappling with diseases like cancer, osteoporosis, anemia, and osteoporosis. Major pharmaceutical firms are conducting social campaigns to encourage healthier lifestyles and supplement usage. For example, in February 2023, Torrent Pharmaceuticals Ltd unveiled a TV campaign named #BeShelcalStrong, aimed at boosting awareness about calcium deficiency and its impacts on daily life.
The upsurge in sedentary lifestyles and consumption of unhealthy diets has resulted in a higher number of people experiencing nutritional deficiencies. Proper body functioning requires varying mineral proportions. Insufficient minerals can lead to problems like fatigue, weak bones, and a compromised immune system. According to NutraIngredients-USA data, iron deficiency is most prevalent in the U.S. population. Additionally, government initiatives promoting healthier lifestyles are further stimulating market growth.
Beyond increased awareness about mineral supplement benefits, key market players are concentrating on inventive product development and exploring exotic ingredients. The rising popularity of plant-based products is also creating growth opportunities. Furthermore, for managing metabolic disorders, consumers are turning to personalized preventive products and services, favoring them over solely curative health practices, thereby fostering market growth.
In contrast to other sectors, the COVID-19 pandemic boosted the demand for mineral supplements. Research from the National Center for Biotechnology Information showed that the infection disproportionately affected individuals with mineral deficiencies. Recent studies propose that higher-than-recommended doses of mineral supplements could aid COVID-19 patients in reducing viral load and hospitalization. Consequently, this surge in demand prompted the introduction of new products. Nonetheless, counterfeit product sales are projected to impede market growth. Economic crises and political conflicts disrupt the supply chain, leading to an increase in locally produced, inexpensive items. Escalating demand and easy availability of mineral supplements have contributed to the proliferation of counterfeit goods.
US RNA Analysis Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Kits & Reagents
Fastest Growth
Kits & Reagents
Growth Rate
4.00% CAGR
Global RNA Analysis Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
RNA Analysis Market Segmental Analysis
The global RNA analysis market is segmented on the basis of technology, product, application, end – use, region. By technology, the market is segmented real time-pcr (QPCR) technology, microarray technology, sequencing technology, and others. By product, the market is segmented into instruments, kits & reagents, cho media mirna & sirna, reverse transcriptases & rt-pcr, rna interference, rna extraction & purification, others, services. By application, the market is segmented into construction of rna expression atlas, infectious diseases & pathogenesis, epigenetics, alternative rna splicing, rna structure & molecular dynamics, development & delivery of rna therapeutics, others. By end - use, the market is segmented into government institutes & academic centers, contract research organizations (CROs), pharmaceutical & biotechnology companies, hospitals & clinics. By region, the market is segmented into North America, Europe, Latin America, Asia- Pacific, Middle East and Africa.
RNA Analysis Market Analysis By Product
In 2022, the kits & reagents products segment established its supremacy in the global market, commanding a substantial share of 59.49% of the total revenue. These premium reagents and kits play a pivotal role in delivering unparalleled efficiency and robust performance, ensuring sequencing outcomes that are both reliable and reproducible. This exceptional level of performance is achieved while keeping costs at a minimum, making this segment an indispensable cornerstone of the market
Conversely, the services segment is poised to chart the fastest CAGR of 11.80% from 2023 to 2030. This accelerated growth trajectory is underpinned by the expanding Research and Development (R&D) activities within the pharmaceutical sector and the escalating investments by governments in life science research. The surge in demand for RNA analysis services is a direct consequence of these trends. Noteworthy players like Eurofins Scientific, Genewiz, and QIAGEN are actively engaged in providing a diverse array of RNA analysis services encompassing mRNA sequencing, transcriptome profiling, and comprehensive end-to-end solutions spanning RNA sample preparation, library construction, sequencing, and data analysis.
RNA Analysis Market Analysis By Application
The infectious diseases and pathogenesis application segment took a commanding lead in the market, accounting for a substantial share of 18.03% in 2022. This segment's ascendancy stems from its pivotal role in understanding the underlying mechanisms of pathogenicity. The accurate identification of susceptible cells assumes paramount importance in comprehending how infections propagate. This has led to a growing adoption of single-cell RNA sequencing (scRNA-sequencing) as a valuable tool to unravel information about cell types that are susceptible to infections. The integration of next-generation sequencing technologies is causing a paradigm shift in tackling infectious diseases and comprehending their pathogenesis, thereby revolutionizing healthcare strategies and patient management. A diverse range of methodologies has emerged to assess gene expression and biomarkers, thus bridging the gap between research and clinical applications.
On the other hand, the epigenetics segment is poised to chart an impressive CAGR of 11.07% from 2023 to 2030. The escalating pharmaceutical interest in unraveling epigenetic intricacies for studying disease prognosis and epidemiology is driving this growth. Furthermore, molecular dynamics is set to emerge as a versatile tool complementing experimental RNA structural investigations. This expansion is forecasted to occur without necessitating substantial methodological advancements, thereby maximizing the potential of molecular dynamic simulations. The pertinence of epigenetic modifications like DNA methylation and histone modifications, which can influence the binding of transcription factors and regulatory proteins, is anticipated to amplify the demand for epigenetic analyses, particularly in the context of understanding gene expression nuances. As the healthcare landscape advances, the role of these segments in shaping disease understanding and treatment approaches becomes increasingly profound.
Global RNA Analysis Market By Application
To get detailed analysis on other segments, Request For Free Sample Report
RNA Analysis Market Regional Insights
In the year 2022, North America secured the largest market share, encompassing 44.10% of the total. This dominance can be attributed to the swift evolution of structure-based drug designs, an escalating emphasis on transcriptomics research, and substantial investments in biopharmaceutical research and development. Moreover, the pronounced uptick in financial allocations for pharmaceutical exploration and drug innovation significantly propels revenue growth for companies operating within this region. This dynamic landscape is fueled by the convergence of research and development initiatives, culminating in an amplified market presence.
On the other hand, the Asia Pacific (APAC) region is poised to chart the swiftest CAGR during the forecast period, projected at 11.23%. This projection is underpinned by the escalating governmental and corporate investments catalyzing biotechnology research across APAC nations. Japan, in particular, boasts substantial governmental and non-governmental support for advancing biotech research, providing substantial funding in the medical and life sciences sectors. This nurturing environment emboldens researchers to proactively explore the realm of transcriptomics.
Furthermore, the APAC region's appeal is magnified by its reputation for cost-effective manufacturing services, attracting manufacturers to set their sights on this promising landscape. Strategic initiatives like partnerships also factor into the growth trajectory. Notably, in January 2020, Genetron Holdings Ltd. forged a strategic partnership with Thermo Fisher Scientific, a move aimed at extending precision cancer monitoring and diagnosis within China's public hospitals. These strategic collaborations augur well for the region's expansion, amplifying its capabilities and visibility on the global stage.
Global RNA Analysis Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
RNA Analysis Market Dynamics
RNA Analysis Market Drivers
Biopharmaceutical Research and Drug Development
- The pharmaceutical and biotech sectors heavily rely on RNA analysis to develop targeted therapies, personalized medicine, and innovative drug candidates. This has fueled substantial demand for RNA analysis techniques.
Transcriptomics Research Expansion
- Increased interest in transcriptomics research, which focuses on studying the entire RNA transcriptome, has boosted the demand for advanced RNA analysis technologies that can provide comprehensive insights into gene expression.
Advancements in Genomic Research
- Rapid advancements in genomic research and technology have accelerated RNA analysis techniques, enabling more accurate and comprehensive insights into gene expression patterns and molecular mechanisms.
RNA Analysis Market Restraints
Bioinformatics Complexity
- Interpreting RNA sequencing data involves complex bioinformatics analysis, which demands specialized skills and resources, potentially hindering adoption in some settings.
Standardization and Reproducibility
- Ensuring consistency, standardization, and reproducibility across different RNA analysis platforms and laboratories is a challenge that needs to be addressed for reliable results.
Data Management Challenges
- The massive amount of data generated from RNA sequencing requires sophisticated data management and analysis infrastructure, which can be complex and resource-intensive.
Request Free Customization of this report to help us to meet your business objectives.
RNA Analysis Market Competitive Landscape
The competitive landscape of the global RNA analysis market is characterized by intense rivalry among established players and innovative entrants, all striving to carve a niche in this rapidly evolving domain. Major companies such as Thermo Fisher Scientific, Illumina, Inc., Agilent Technologies, and Qiagen AG dominate the market with their extensive product portfolios, advanced RNA sequencing platforms, and robust bioinformatics solutions.
Innovation stands as a cornerstone in this landscape, with companies consistently launching cutting-edge technologies to cater to diverse research needs. Mergers, acquisitions, and strategic collaborations are also prominent strategies employed to expand market footholds and access complementary technologies. The increasing demand for personalized medicine and the advent of precision genomics have led to collaborations between RNA analysis market leaders and pharmaceutical giants to develop targeted therapies and novel drug candidates. Additionally, academic and research institutions contribute to the competition by fostering innovation and driving the adoption of RNA analysis technologies across various fields.
RNA Analysis Market Top Player’s Company Profiles
- Thermo Fisher Scientific Inc. (USA)
- Illumina, Inc. (USA)
- Agilent Technologies, Inc. (USA)
- Qiagen AG (Germany)
- PerkinElmer, Inc. (USA)
- Eurofins Scientific SE (Luxembourg)
- Genewiz (a Brooks Life Sciences Company) (USA)
- Bio-Rad Laboratories, Inc. (USA)
- Merck KGaA (Germany)
- Promega Corporation (USA)
- Fluidigm Corporation (USA)
- Oxford Nanopore Technologies Ltd. (United Kingdom)
- Takara Bio Inc. (Japan)
- Zymo Research Corporation (USA)
- BGI Group (China)
- NuGEN Technologies, Inc. (USA)
- Lexogen GmbH (Austria)
- Pacific Biosciences of California, Inc. (USA)
- Roche Diagnostics (Switzerland)
- Bio-Techne Corporation (USA)
RNA Analysis Market Recent Developments
- In 2023, Thermo Fisher Scientific announced the launch of its new RNA analysis platform, the Ion GeneStudio S5 Prime.
- In 2023, Agilent Technologies introduced a new line of RNA analysis reagents for use with its Bioanalyzer 2100 platform.
- In 2023, Illumina announced the launch of its new RNA analysis software, the BaseSpace RNA Analysis Suite.
RNA Analysis Key Market Trends
- Long Read Sequencing: Advances in long-read sequencing technologies are enabling the accurate sequencing of full-length RNA molecules, enhancing the understanding of alternative splicing, isoforms, and complex gene structures.
- Epitranscriptomics: The study of RNA modifications (epitranscriptomics) is emerging as a significant trend, as researchers explore how modifications affect gene expression, translation, and disease mechanisms.
- Single-Cell RNA Sequencing (scRNA-seq): The trend towards scRNA-seq is gaining momentum, enabling researchers to study individual cells' gene expression patterns, uncovering cellular heterogeneity and novel insights into biological processes.
RNA Analysis Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Product types team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our global RNA analysis market analysis, the global RNA analysis market is poised for a transformative journey driven by a nexus of factors. The market's trajectory is significantly influenced by the convergence of cutting-edge genomic research, burgeoning biopharmaceutical endeavors, and the surging demand for personalized medicine. As companies vie for supremacy, a dynamic competitive landscape emerges, characterized by innovation, strategic collaborations, and comprehensive solutions. The market's growth is tempered by challenges such as cost complexities, data management, and bioinformatics intricacies, necessitating concerted efforts to address these hurdles. However, trends like single-cell analysis, epitranscriptomics, and AI integration provide avenues for breakthroughs.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 15.5 billion |
| Market size value in 2031 | USD 22.06 billion |
| Growth Rate | 4.00% |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on RNA Analysis Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on RNA Analysis Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the RNA Analysis Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the RNA Analysis Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the RNA Analysis Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the RNA Analysis Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
